IQ EQ Fund Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-122,892
| Closed | -$65.1K | – | 249 |
|
|
2022
Q4 | $65.1K | Buy |
122,892
+6,112
| +5% | +$3.24K | 0.01% | 226 |
|
|
2022
Q3 | $85K | Sell |
116,780
-107,441
| -48% | -$78.2K | 0.02% | 206 |
|
|
2022
Q2 | $256K | Buy |
224,221
+10,752
| +5% | +$12.3K | 0.05% | 172 |
|
|
2022
Q1 | $438K | Buy |
213,469
+9,960
| +5% | +$20.4K | 0.07% | 165 |
|
|
2021
Q4 | $586K | Buy |
203,509
+18,574
| +10% | +$53.5K | 0.09% | 167 |
|
|
2021
Q3 | $784K | Sell |
184,935
-777,697
| -81% | -$3.3M | 0.12% | 162 |
|
|
2021
Q2 | $5.09M | Buy |
962,632
+241,045
| +33% | +$1.28M | 0.78% | 37 |
|
|
2021
Q1 | $3.36M | Buy |
721,587
+649,418
| +900% | +$3.02M | 0.59% | 51 |
|
|
2020
Q4 | $238K | Buy |
72,169
+40,617
| +129% | +$134K | 0.06% | 214 |
|
|
2020
Q3 | $104K | Buy |
31,552
+19,266
| +157% | +$63.5K | 0.03% | 191 |
|
|
2020
Q2 | $41K | Buy |
+12,286
| New | +$41K | 0.01% | 187 |
|